David Tuveson Archives - Cold Spring Harbor Laboratory

Newsstand Menu

Select stories by tag

Cancer cell’s “self eating” tactic may be its weakness

July 1, 2019

Pancreatic cancer cells are eating their own mitochondria to survive and spread. New research reveals how, hinting at a possible new drug target.

Sugars that coat proteins are a possible drug target for pancreatitis

June 20, 2019

CA19-9, a complex sugar structure coating proteins, represents a possible drug target for treatment of pancreatitis and prevention of pancreatic cancer.

Special fibroblasts help pancreatic cancer cells evade immune detection

June 13, 2019

Researchers found a specific type of cancer-associated fibroblast interacts with the immune system to help pancreatic cancer cells stay under the radar.

Fighting cancer in 3D

June 7, 2019

David Tuveson, Director of the CSHL Cancer Center, shares insights about his work on organoid technology.

Yacht race raises $6,500 for cancer research

November 29, 2018

The Masthead Cove Yacht Club raised $6,500 from their annual race, which will fund cancer research.

Turning cells against pancreatic cancer

October 26, 2018

Researchers have found a way to turn cancer-supporting cells into cells that restrict the cancerous growth in the pancreas.

Nation’s cancer centers endorse HPV vaccination

June 8, 2018

Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine

Organoid profiling personalizes treatments for pancreatic cancer

May 31, 2018

Pancreatic organoids grown from patients' tumors make precision medicine possible

David Tuveson elected to the AACR Board of Directors

April 13, 2018

CSHL Professor David Tuveson was elected to the Board of Directors of the American Association for Cancer Research for the 2018 - 2021 term

Halfway around the world, a reunion of friends opens door to a cancer discovery

August 31, 2017

After interviewing for a position in a pancreatic cancer lab at Cold Spring Harbor Laboratory, 7,000 miles from his hometown in South Korea, Chang-il.

CSHL to lead international team developing next-generation organoid cancer research

May 11, 2017

Cold Spring Harbor Laboratory (CSHL) has been awarded a research subcontract by Leidos Biomedical Research to lead a Cancer Model Development Center (CMDC) for pancreatic, breast, colorectal, lung, liver and other upper-gastrointestinal cancers.

Newly discovered mutations impair key cell pathways in pancreatic cancer

May 8, 2017

Researchers have found important new clues to the development of pancreatic cancer.

Discovery of distinct cell subtypes around tumors helps explain why pancreatic cancer is so hard to treat

February 23, 2017

Researchers finds that stroma,“wound”-like tissue that surrounds the tumors, helps explain why pancreatic cancer is so resistant to treatment.

CSHL joins NCI-designated cancer centers in endorsing updated HPV vaccination recommendations

January 11, 2017

Dr. Stillman and Dr. Tuveson joined with the leaders of other institutions nationwide in endorsing a statement regarding the HPV vaccine.

Dr. David Tuveson named Director, NCI-Designated Cancer Center at Cold Spring Harbor Laboratory

November 29, 2016

Dr. David Tuveson, M.D., Ph.D., succeeds Dr. Bruce Stillman as Director of the Cold Spring Harbor Laboratory (CSHL) Cancer Center.

CSHL Story archive for Tag: David Tuveson